154 related articles for article (PubMed ID: 7975756)
1. [Nootropic drugs: definition, classification, mechanism of action, clinical effectiveness, substances].
Kuhlmey J
Z Arztl Fortbild (Jena); 1994 Sep; 88(9):697-701. PubMed ID: 7975756
[No Abstract] [Full Text] [Related]
2. Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art.
Fariello RG
Funct Neurol; 1997; 12(3-4):221-5. PubMed ID: 9218984
[No Abstract] [Full Text] [Related]
3. Drugs for cognitive loss and dementia.
Treat Guidel Med Lett; 2010 Mar; 8(91):19-24. PubMed ID: 20179667
[No Abstract] [Full Text] [Related]
4. Utilization of the Dementia Rating Scale-2 and cognitive enhancers in the diagnosis and treatment of cognitive disorders and dementia.
Caston JC; Diehl LA; Hedgepath AW
J S C Med Assoc; 2004 Feb; 100(2):32-8. PubMed ID: 15040232
[No Abstract] [Full Text] [Related]
5. Restriction in complex activities of daily living in MCI: impact on outcome.
Hussain H
Neurology; 2007 May; 68(18):1544-5; author reply 1545. PubMed ID: 17470764
[No Abstract] [Full Text] [Related]
6. Outcomes for clinical trials in mild-to-moderate dementia to evaluate drugs with presumably symptomatic effects.
Frolich L
J Nutr Health Aging; 2007; 11(4):357-8. PubMed ID: 17653499
[No Abstract] [Full Text] [Related]
7. Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Gauthier S; Bodick N; Erzigkeit E; Feldman H; Geldmacher DS; Huff J; Mohs R; Orgogozo JM; Rogers S
Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():6-7. PubMed ID: 9305507
[No Abstract] [Full Text] [Related]
8. Cognitive issues in Parkinson's disease.
Elmer L
Neurol Clin; 2004 Oct; 22(3 Suppl):S91-S106. PubMed ID: 15501368
[No Abstract] [Full Text] [Related]
9. [Challenging pharmacotherapy in dementia].
Ihl R
MMW Fortschr Med; 2009 Mar; 151(13):46-8. PubMed ID: 19504818
[No Abstract] [Full Text] [Related]
10. Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Reisberg B; Schneider L; Doody R; Anand R; Feldman H; Haraguchi H; Kumar R; Lucca U; Mangone CA; Mohr E; Morris JC; Rogers S; Sawada T
Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():8-18. PubMed ID: 9305508
[TBL] [Abstract][Full Text] [Related]
11. [Dementing disorders. What benefits do the new anti-dementia drugs have?].
Ihl R
MMW Fortschr Med; 2002 May; Suppl 2():24-6, 28-9. PubMed ID: 12070846
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychiatric outcome for clinical trials.
Robert P; Verhey FR; Aalten P; Cortes F; Byrne EJ
J Nutr Health Aging; 2007; 11(4):345-7. PubMed ID: 17653496
[No Abstract] [Full Text] [Related]
13. [Modern therapy for dementia].
Padberg F; Möller HJ; Bottlender R; Hampel H
MMW Fortschr Med; 2005 May; 147 Spec No 2():71-4, 76-7. PubMed ID: 15968877
[TBL] [Abstract][Full Text] [Related]
14. Antidementia drugs: are they effective in improving quality of life for elderly persons with dementia?
Homma A
Int Psychogeriatr; 1995; 7(3):363-6. PubMed ID: 8821343
[No Abstract] [Full Text] [Related]
15. [Treatment with nootropic drugs].
Barocka A
Fortschr Med; 1990 Mar; 108(9):178-80. PubMed ID: 2187782
[TBL] [Abstract][Full Text] [Related]
16. Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Ferris SH; Lucca U; Mohs R; Dubois B; Wesnes K; Erzigkeit H; Geldmacher D; Bodick N
Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():34-8. PubMed ID: 9305514
[No Abstract] [Full Text] [Related]
17. [Possibilities and limits of therapy of cognition disorders in the elderly].
Hoyer S
Z Gerontol Geriatr; 1995; 28(6):457-62. PubMed ID: 8581765
[TBL] [Abstract][Full Text] [Related]
18. Translation issues in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Feldman H; Anand R; Blesa R; Dubois B; Gray J; Homma A; Mohr E; Morris JC; Parys W; Raschig A; Robillard A
Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():61-4. PubMed ID: 9305520
[No Abstract] [Full Text] [Related]
19. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
Tariska P; Paksy A
Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
[TBL] [Abstract][Full Text] [Related]
20. Galantamine for Alzheimer's disease and mild cognitive impairment.
Cusi C; Cantisani TA; Celani MG; Incorvaia B; Righetti E; Candelise L;
Neuroepidemiology; 2007; 28(2):116-7. PubMed ID: 17409773
[No Abstract] [Full Text] [Related]
[Next] [New Search]
